Bri-Chem (BRY) Q2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2024 earnings summary
22 Oct, 2026Executive summary
Q2 2024 sales were $19.1M, down 24% YoY; lower US drilling activity weighed on revenue, while Canadian blending and packaging sales grew.
Adjusted EBITDA was $707K and net loss was $488K; both declined from Q2 2023, with margin pressure from lost sales and foreign exchange loss.
Financial highlights
Q2 sales fell to $19.106M from $25.229M; H1 sales were $40.477M vs. $52.430M, down $11.953M YoY.
Q2 operating earnings were $620K vs. $1.216M; H1 operating earnings were $476K vs. $2.513M.
Q2 adjusted EBITDA was $707K vs. $1.972M; H1 adjusted EBITDA was $264K vs. $3.587M.
Q2 net loss was $488K vs. net earnings of $553K; H1 net loss was $1.994M vs. net earnings of $818K.
Adjusted net loss was $584K in Q2 and $2.351M in H1, compared with adjusted net earnings of $714K and $1.105M in the respective 2023 periods.
Outlook and guidance
Near-term priorities are controlling inventory and maintaining balance-sheet strength until US drilling activity and demand for products improve.
Canadian oil drilling activity is expected to increase in H2 with Trans Mountain Pipeline expansion activation; Canadian natural gas demand has risen modestly ahead of higher LNG export capacity.
Latest events from Bri-Chem
- Sales grew 16%, but higher costs and lower margins cut adjusted EBITDA 34%.BRY
Q1 2023 - Q4 adjusted EBITDA rose 35%, while FY operating earnings fell 40%.BRY
Q4 2023 - Adjusted EBITDA rose, but lower U.S. drilling sales weighed on Q2 revenue.BRY
Q2 2023 - Lower U.S. rig activity and margin pressure cut Q3 earnings; a modest 2024 recovery is possible.BRY
Q3 2023 - Lower drilling activity drove a 21% sales decline and a $443K Adjusted EBITDA loss.BRY
Q1 2024 - Weaker US drilling drove lower Q3 sales, earnings and Adjusted EBITDA.BRY
Q3 2024 - Lower sales and a $1.1M bad-debt write-off drove FY adjusted EBITDA negative.BRY
Q4 2024 - Lower US drilling cut sales 7%, while adjusted EBITDA returned to positive territory.BRY
Q1 2025 - Q2 earnings improved as sales rose, but Canadian demand remains soft.BRY
Q2 2025